Farzin Fath-Ordoubadi

Showing 1-16 of 16 articles

Author Alexandre Abizaid

Coronary interventions

Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial

Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos P, Milewski K, Botelho R, Costa R, Bangalore S

December 7, 2018 | 10.4244/EIJ-D-18-00762

Author Vasim Farooq

Coronary interventions

Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study

Farooq V, Serruys P, Mustafa A, Mamas M, Malik N, Alhous H, El-Omar M, Hendry C, Rana D, Shelton D, Wright P, Narine N, Clarke B, Keavney B, Fath-Ordoubadi F, Fraser D

April 8, 2016 | 10.4244/EIJV11I14A315

Author Vasim Farooq

Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?

Farooq V, Mamas M, Frase D, El-Omar M, Clarke B, Fath-Ordoubadi F

March 20, 2015 | 10.4244/EIJV10I11A224

Author Mamas Mamas

Minimising radial injury: prevention is better than cure

Mamas M, Fraser D, Ratib K, Fath-Ordoubadi F, El-Omar M, Nolan J, Neyses L

November 20, 2014 | 10.4244/EIJV10I7A142

Author Samer Arnous

Thrombus capture by withdrawal of an open filter device: a useful treatment for large non-occlusive coronary thrombus

Arnous S, Agelaki M, Shakhshir N, Kelly D, Ordoubadi F, Mamas M, Fraser D

October 20, 2014 | 10.4244/EIJV10I6A120

Author Vasim Farooq

Lessons from acute and late scaffold failures in the ABSORB EXTEND trial: have we really learned them all?

Farooq V, Fraser D, El-Omar M, Mamas M, Clarke B, Fath-Ordoubadi F

August 19, 2014 | 10.4244/EIJV10I4A73

Author Paul D. Williams

Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms

Williams P, Mamas M, Morgan K, El-Omar M, Clarke B, Bainbridge A, Fath-Ordoubadi F, Fraser D

June 27, 2012 | 10.4244/EIJV8I2A41

Author Cara Hendry

Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience

Hendry C, Fraser D, Eichhöfer J, Mamas M, Fath-Ordoubadi F, El-Omar M, Williams P

May 15, 2012 | 10.4244/EIJV8I1A13

Author Gian Battista Danzi

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study

Danzi G, Chevalier B, Urban P, Fath-Ordoubadi F, Carrié D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez J, Sagic D, Laanmets P, Strupp G, West N, Paunovic D

May 15, 2012 | 10.4244/EIJV8I1A17

Author Mamas Mamas

Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience

Mamas M, Farooq V, Latib A, Sastry S, D’souza S, Williams P, Wiper A, Neyses L, El-Omar M, Fraser D, Fath-Ordoubadi F

February 21, 2012 | 10.4244/EIJV7I10A188

Author Satheesh Nair

Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention

Nair S, Fath-Ordoubadi F, Clarke B, El-Omar M, Foley J, Fraser D, Mahadevan V, Neyses L, Khattar R, Mamas M

March 21, 2011

Author Clare Appleby

Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice

Appleby C, Khattar R, Morgan K, Clarke B, Curzen N, Neyses L, Fath-Ordoubadi F

January 20, 2011

Author Mamas Mamas

Use of the Heartrail II catheter as a distal stent delivery device; an extended case series

Mamas M, Eichhofer E, Hendry C, El-Omar M, Clarke B, Neyses L, Fath-Ordoubadi F, Fraser D

June 30, 2009 | 10.4244/EIJV5I2A41

Author Mamas Mamas

The role of thrombectomy and distal protection devices during percutaneous coronary interventions

Mamas M, Fraser D, Fath-Ordoubadi F

May 13, 2008

Author Bernard Chevalier

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D

February 20, 2007

Author Jonas Eichhöfer

Adjunctive Antiplatelet / Antithrombotic therapy in percutaneous coronary intervention

Eichhöfer J, Fraser D, Fath-Ordoubadi F

November 20, 2005

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke